Below, Select looks at what it means to have a 600 credit score and the types of credit cards you'd be able to qualify for with it. According to FICO® Score, 15.5% of the population has a credit ...

While it can be more difficult to get approved for certain premium cards with a credit score of 600 or below, solid credit card options are still available. We’ve done the research, and these ...

Ocrevus (ocrelizumab) was approved to treat PPMS in 2017. The first dose is given intravenously in two 300-milligram (mg) doses two weeks apart. After that, it's given in 600-milligram (mg) doses once ...

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

Low dose birth control pills may have fewer side effects compared with older, higher-dose ones, but certain groups may still have increased health risks. If they aren’t taken correctly ...

In its latest guidance, released Wednesday, the CDC recommends that adults aged 65 and older, as well as individuals with weakened immune systems, receive a second dose of the updated vaccine six ...

Roche is looking to use Dyno’s technologies to target neurological diseases, a big focus at the Swiss pharma, with multiple sclerosis blockbuster Ocrevus serving as its best-selling asset.

In September, the Swiss pharma won back-to-back FDA approvals for subcutaneous versions of its multiple sclerosis drug Ocrevus and cancer immunotherapy Tecentriq. Dubbed Ocrevus Zunovo ...

Roche’s top-performing asset was the multiple sclerosis drug Ocrevus; sales increased 11% to 1.69 billion Swiss francs. Sales of Vabysmo, an age-related macular degeneration (AMD) treatment ...

Today, a brief rundown of news from Merck & Co. and Roche, as well as updates from Sangamo Therapeutics, UCB and Catalent that you may have missed. MacroGenics, a developer of antibody medicines for ...